WallStreetZenWallStreetZen

NASDAQ: GALT
Galectin Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their GALT stock forecasts and price targets.

Forecast return on equity

Is GALT forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is GALT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GALT revenue forecast

What is GALT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$36.3M
Avg 2 year Forecast
$179.7M
Avg 3 year Forecast
$385.2M

GALT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GALT$2.41N/AN/A
BLUE$1.37$5.71+318.53%Hold
CLLS$2.67$6.00+124.72%Buy
CTMX$2.19$3.13+42.69%Hold
ARMP$4.10$7.00+70.73%Buy

Galectin Therapeutics Stock Forecast FAQ

What is GALT's revenue growth forecast for 2025-2027?

(NASDAQ: GALT) Galectin Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Galectin Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GALT's revenue for 2025 to be $2,246,343,222, with the lowest GALT revenue forecast at $2,246,343,222, and the highest GALT revenue forecast at $2,246,343,222. On average, 1 Wall Street analysts forecast GALT's revenue for 2026 to be $11,113,585,176, with the lowest GALT revenue forecast at $11,113,585,176, and the highest GALT revenue forecast at $11,113,585,176.

In 2027, GALT is forecast to generate $23,826,576,623 in revenue, with the lowest revenue forecast at $23,826,576,623 and the highest revenue forecast at $23,826,576,623.

If you're new to stock investing, here's how to buy Galectin Therapeutics stock.

What is GALT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GALT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is GALT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GALT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.